Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention
详细信息 查看全文
- 作者：Yuanyuan Hao ; Qun Lu ; Tao Li ; Guodong Yang ; Peijing Hu…
- 关键词：Non ; ST ; elevation myocardial infarction ; Diabetes mellitus ; Hyperglycemia ; Major adverse cardiac events
- 刊名：BMC Cardiovascular Disorders
- 出版年：2017
- 出版时间：December 2017
- 年：2017
- 卷：17
- 期：1
- 全文大小：642KB
- 刊物主题：Cardiology; Cardiac Surgery; Angiology; Blood Transfusion Medicine; Internal Medicine; Medicine/Public Health, general;
- 出版者：BioMed Central
- ISSN：1471-2261
- 卷排序：17
文摘
BackgroundThe association between admission hyperglycemia and adverse outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI) has not been well studied, and the optimal plasma glucose cut-off values for prognosis for NSTEMI patients with and without diabetes have not been determined.